Beta blockers are among the most versatile medications in cardiology, and the propranolol vs metoprolol comparison comes up frequently because these two drugs, while sharing a class, serve notably different roles. Propranolol was the first clinically successful beta blocker, work that helped earn its inventor a Nobel Prize, while metoprolol became a go-to choice for heart failure and post-heart-attack care. Together they account for millions of prescriptions annually in the United States. Their differences in selectivity, off-label uses, and side-effect profiles make the choice between them clinically significant — but that choice belongs to your prescriber. Both drugs are prescription-only, and this guide is general education, not a substitute for medical advice. Visit our medical conditions guide for more drug comparisons.
Important safety note: Never start, stop, or change the dose of a beta blocker on your own. Stopping abruptly can trigger dangerous rebound effects (see below). This article does not provide a dosing plan; only your prescriber can set or adjust your dose. For a suspected overdose or accidental extra dose, call Poison Control at 1-800-222-1222; for chest pain, fainting, or trouble breathing, call 911.
How Beta Blockers Work
Beta blockers reduce the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) by blocking beta-adrenergic receptors. This slows the heart rate, reduces the force of heart contractions, and lowers blood pressure. There are two main types of beta receptors relevant here: beta-1 receptors, found primarily in the heart, and beta-2 receptors, found in the lungs, blood vessels, and other tissues.
The critical distinction between propranolol and metoprolol lies in selectivity. Propranolol is a non-selective beta blocker, meaning it blocks both beta-1 and beta-2 receptors. Metoprolol is cardioselective (beta-1 selective), primarily affecting the heart while having less impact on the lungs and peripheral blood vessels — though this selectivity is relative and diminishes at higher doses. This distinction has practical implications for patients with asthma, diabetes, and peripheral vascular disease, all of which your clinician factors into the choice.
Never Stop a Beta Blocker Abruptly
This is the most important safety point in any beta blocker comparison. Do not stop propranolol or metoprolol suddenly, skip doses, or run out without a plan. During ongoing beta-blockade, the body increases the number and sensitivity of adrenergic receptors; if the drug is withdrawn abruptly, the heart can become oversensitive to circulating adrenaline. This can cause rebound high blood pressure, worsening chest pain (angina), abnormal heart rhythms, and — in people with coronary artery disease — a heart attack. Case series have documented unstable angina and heart attacks after abrupt propranolol withdrawal.
If you and your clinician decide to stop a beta blocker, it is done as a gradual, individualized taper over days to weeks (longer for higher-risk heart patients), with monitoring. The specifics are set by your prescriber based on your dose, condition, and risk — which is exactly why this article does not print a taper schedule. If you have missed doses or are running low, contact your prescriber or pharmacist promptly rather than simply stopping.
Propranolol vs Metoprolol: Comparison Table
| Feature | Propranolol (Inderal) | Metoprolol (Lopressor / Toprol XL) |
|---|---|---|
| Selectivity | Non-selective (beta-1 and beta-2) | Cardioselective (beta-1) |
| FDA-approved uses | Hypertension, angina, certain arrhythmias, migraine prevention, essential tremor, pheochromocytoma, post-MI | Hypertension, angina, heart failure (succinate), post-MI |
| Common off-label uses | Performance/situational anxiety, akathisia, portal hypertension | SVT and atrial fibrillation rate control, anxiety (less common) |
| Lipophilicity | Highly lipophilic (crosses the blood-brain barrier) | Moderately lipophilic |
| Half-life | ~3-6 hours (IR), ~8-10 hours (LA) | ~3-7 hours (tartrate), ~12 hours (succinate XL) |
| Asthma / reactive airways | Generally avoided (blocks beta-2 in lungs) | Used with caution; still generally avoided when possible |
| Diabetes | Can mask low-blood-sugar warning signs | Less likely to mask hypoglycemia |
| CNS side effects | More common (vivid dreams, fatigue) | Less common |
| Generic cost (30-day) | Low-cost generic (varies by pharmacy) | Low-cost generic (varies by pharmacy) |
The dose ranges and equivalences that clinicians use are deliberately not listed here, because appropriate dosing depends on your diagnosis, other medications, kidney and liver function, and response — factors only your prescriber can weigh.
Conditions and Effectiveness
Hypertension
Both medications lower blood pressure, though beta blockers are no longer considered first-line for uncomplicated hypertension under current ACC/AHA guidelines. They remain appropriate when high blood pressure coexists with conditions like heart failure, post-heart-attack care, or atrial fibrillation. Metoprolol succinate (Toprol XL) is commonly chosen for blood pressure because of its once-daily dosing and cardioselectivity.
Heart Failure
Metoprolol succinate is one of only three beta blockers with strong evidence for reducing mortality in heart failure with reduced ejection fraction (HFrEF), alongside carvedilol and bisoprolol. Propranolol is not used for this purpose and could potentially worsen heart failure. This is one area where the choice is clear-cut: metoprolol succinate is the appropriate agent. For more on metoprolol, read our metoprolol side effects guide.
Anxiety and Performance Anxiety
Propranolol is the beta blocker most often used off-label for anxiety-related situations, particularly performance and situational anxiety. Its non-selective action and ability to cross the blood-brain barrier help blunt the physical symptoms of anxiety — such as tremor, racing heartbeat, and sweating. Clinicians sometimes prescribe a low dose taken before a specific stressful event, but the appropriate drug, dose, and timing must be individualized by a prescriber, who will also screen for reasons it may be unsafe (asthma, low heart rate, certain heart conditions). This is not something to source or self-dose. For more details, check our propranolol side effects article.
Migraine Prevention
Propranolol is FDA-approved for migraine prevention and has one of the strongest evidence bases among beta blockers for this indication; the American Academy of Neurology has rated it among the best-supported preventive options. Metoprolol also has supportive evidence for migraine prevention but is not FDA-approved for that use.
Essential Tremor
Propranolol is a first-line medication for essential tremor, helping a substantial share of patients. Metoprolol tends to be less effective for tremor, because its cardioselectivity means less beta-2 blockade in skeletal muscle.
Side Effects Comparison
Both medications share common beta blocker side effects: fatigue, dizziness, bradycardia (slow heart rate), cold hands and feet, and sexual dysfunction. However, the frequency and severity differ based on their selectivity profiles.
Propranolol’s non-selective beta-2 blockade can cause bronchospasm, which is why it is generally avoided in people with asthma or reactive airway disease. It also more readily masks the fast heartbeat and tremor that can warn people with diabetes of low blood sugar (hypoglycemia) — a reason for extra caution and glucose monitoring in that group. Its ability to enter the brain produces more central nervous system effects, including vivid dreams, sleep disturbances, and fatigue. According to the Mayo Clinic, these CNS effects tend to be more pronounced with propranolol than with more water-soluble beta blockers.
Metoprolol’s cardioselectivity means fewer respiratory and metabolic side effects, though — again — selectivity is dose-dependent and fades at higher doses. It is often better tolerated in patients with well-controlled asthma (where beta blockers are still used cautiously), diabetes, and peripheral vascular disease. Metoprolol tartrate’s short half-life requires twice-daily dosing, which some find inconvenient, while the succinate extended-release form allows once-daily dosing. Report any bothersome or severe side effects — very slow heart rate, fainting, breathing trouble, or mood changes — to your prescriber rather than adjusting the drug yourself.
Drug Interactions
Both medications can interact with calcium channel blockers such as verapamil and diltiazem, potentially causing severe slow heart rate or heart block. They also interact with other blood-pressure medications, digoxin, and clonidine (clonidine should not be stopped abruptly while on a beta blocker). Propranolol additionally interacts with drugs metabolized by the CYP1A2 and CYP2D6 enzymes, including theophylline, certain antipsychotics, and some antidepressants. Give your prescriber and pharmacist a full list of your medications and supplements so interactions can be checked. Compare metoprolol further with our metoprolol vs atenolol guide.
Frequently Asked Questions
Can I use metoprolol instead of propranolol for anxiety?
Metoprolol can reduce heart rate and some physical anxiety symptoms, but it is generally considered less effective than propranolol for performance anxiety, because it crosses into the brain less readily and does less to blunt tremor and sweating. Any use for anxiety should be discussed with, and prescribed by, a clinician.
Which beta blocker causes less fatigue?
Metoprolol generally causes less fatigue than propranolol because it is less lipophilic and has fewer central nervous system effects. If fatigue is a significant concern, your clinician may consider metoprolol or a more water-soluble beta blocker like atenolol — but do not switch on your own.
Is propranolol or metoprolol better for atrial fibrillation?
Metoprolol is more commonly used for atrial fibrillation rate control and is available in an IV form for acute control in hospitals, with oral forms standard for outpatient management. Propranolol can also control heart rate in AF but is used less often for this purpose. Your cardiologist decides based on your overall picture.
Can I switch from propranolol to metoprolol?
Only under medical supervision. The two drugs are not dose-equivalent, and switching requires a clinician to choose the right starting dose and monitor the change — abruptly stopping one before starting the other can be dangerous. Do not attempt a self-directed switch.
What should I do if I miss a dose?
Follow the specific instructions from your pharmacist or the drug label, and do not double up to “catch up” unless told to. If you have missed several doses, are running out, or are considering stopping, contact your prescriber — because of rebound risk, beta blockers should not simply be discontinued.
The Bottom Line
The propranolol vs metoprolol decision comes down to what the medication is meant to do — and it is a decision for your clinician. Propranolol is often preferred for performance anxiety, migraine prevention, and essential tremor thanks to its non-selective action and brain penetration. Metoprolol is the better fit for heart failure, post-heart-attack care, and many blood-pressure situations because of its cardioselectivity, especially in patients with asthma or diabetes. Both are affordable generics. If your doctor has prescribed one specifically, it is almost certainly because your diagnosis and medical history point to that particular beta blocker. Take it exactly as prescribed, never stop it abruptly, and bring any questions or side effects to your prescriber.
Sources
- MedlinePlus — Propranolol; Metoprolol (U.S. National Library of Medicine)
- Mayo Clinic — Propranolol (oral route) description and precautions
- American College of Cardiology / American Heart Association — Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure
- American Academy of Neurology — Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention
- FDA / DailyMed — prescribing information for propranolol and metoprolol